Your request to link to rcsb for BDBM50150484

• 1VYF: schistosoma mansoni fatty acid binding protein in complex with oleic acid (10.1021/BI048505F )
• 4JKV: structure of the human smoothened 7tm receptor in complex with an antitumor agent (10.1038/NATURE12167 )
• 7CRL: structure of chloride ion pumping rhodopsin (clr) with ntq motif 50 ps after light activation (10.1073/PNAS.2020486118 )
• 7CRI: 1 ps structure of chloride ion pumping rhodopsin (clr) with ntq motif (10.1073/PNAS.2020486118 )
• 7CRJ: dark state structure of chloride ion pumping rhodopsin (clr) with ntq motif (10.1073/PNAS.2020486118 )
• 7CRK: 2ps structure of chloride ion pumping rhodopsin (clr) with ntq motif (10.1073/PNAS.2020486118 )
• 7CRT: structure of chloride ion pumping rhodopsin (clr) with ntq motif 100 ps after light activation (0.17mj/mm2) (10.1073/PNAS.2020486118 )
• 7CRS: structure of chloride ion pumping rhodopsin (clr) with ntq motif 100 ps after light activation (0.90mj/mm2) (10.1073/PNAS.2020486118 )
• 7CRX: structure of chloride ion pumping rhodopsin (clr) with ntq motif 100 ps after light activation (2.63mj/mm2) (10.1073/PNAS.2020486118 )
• 7CRY: structure of chloride ion pumping rhodopsin (clr) with ntq motif 100 ps after light activation (6.49 mj/mm2) (10.1073/PNAS.2020486118 )
• 4ZJ8: structures of the human ox1 orexin receptor bound to selective and dual antagonists (10.1038/NSMB.3183 )
• 4ZJC: structures of the human ox1 orexin receptor bound to selective and dual antagonists (10.1038/NSMB.3183 )
• 7URD: human porcn in complex with lgk974 and wnt3a peptide (10.1038/S41586-022-04952-2 )
• 7FEE: crystal structure of protein l (10.1038/S41589-022-01038-Y )
• 5OM1: structure of the a2a-star2-bril562-compound 4e complex at 2.1a obtained from in meso soaking experiments (1 hour soak). (10.1038/S41598-017-18570-W )
• 5OM4: structure of the a2a-star2-bril562-compound 4e complex at 1.86a obtained from in meso soaking experiments (24 hour soak). (10.1038/S41598-017-18570-W )
• 2FTB: crystal structure of axolotl (ambystoma mexicanum) liver bile acid-binding protein bound to oleic acid (10.1002/PROT.20961 )
• 6JYF: structure of light-state marine bacterial chloride importer, nm-r3, with pulse laser (nd-1%) at 140k. (10.1126/SCIADV.AAY2042 )
• 5G28: the crystal structure of light-driven chloride pump clr at ph 6.0. (10.1038/NCOMMS12677 )
• 1DKF: crystal structure of a heterodimeric complex of rar and rxr ligand- binding domains (10.1016/S1097-2765(00)80424-4 )
• 4U9N: structure of a membrane protein (10.1038/NCOMMS6374 )
• 4X6D: cd1a ternary complex with endogenous lipids and bk6 tcr 04-mar-15 4x6d 1 title (10.1038/NI.3098 )
• 5WIV: structure of the sodium-bound human d4 dopamine receptor in complex with nemonapride (10.1126/SCIENCE.AAN5468 )
• 5WIU: structure of the human d4 dopamine receptor in complex with nemonapride (10.1126/SCIENCE.AAN5468 )
• 5NLX: a2a adenosine receptor room-temperature structure determined by serial millisecond crystallography (10.1038/S41467-017-00630-4 )
• 6SU4: crystal structure of the 48c12 heliorhodopsin in the blue form at ph 4.3 (10.1073/PNAS.1915888117 )
• 6SU3: crystal structure of the 48c12 heliorhodopsin in the violet form at ph 8.8 (10.1073/PNAS.1915888117 )
• 7BMH: crystal structure of a light-driven proton pump lr (mac) from leptosphaeria maculans (10.1038/S42003-021-02326-4 )
• 4NYQ: in-vivo crystallisation (midguts of a viviparous cockroach) and structure at 1.2 a resolution of a glycosylated, lipid-binding, lipocalin-like protein (10.1107/S2052252516008903 )
• 7W7H: s suis faka-fakb2 complex structure (10.1126/SCIADV.ABQ3944 )
• 3V2R: compcc in complex with fatty acids
• 6PT2: crystal structure of the active delta opioid receptor in complex with the peptide agonist kgchm07 (10.1126/SCIADV.AAX9115 )
• 3NY8: crystal structure of the human beta2 adrenergic receptor in complex with the inverse agonist ici 118,551 (10.1021/JA105108Q )
• 7URA: human porcn in complex with palmitoleoyl-coa (10.1038/S41586-022-04952-2 )
• 6E12: crystal structure of the alr8543 protein in complex with oleic acid and magnesium ion from nostoc sp. pcc 7120, northeast structural genomics consortium target nsr141
• 6ABA: the crystal structure of the photoactivated state of nonlabens marinus rhodopsin 3
• 6YT4: crystal structure of the n112a mutant of the light-driven sodium pump kr2 in the pentameric form, ph 8.0 (10.3390/CRYST10060496 )
• 7A4P: structure of small high-light grown chlorella ohadii photosystem i (10.1038/S41477-021-00983-1 )
• 6C1R: crystal structure of human c5a receptor in complex with an orthosteric antagonist pmx53 and an allosteric antagonist avacopan (10.1038/S41594-018-0067-Z )
• 7Z0D: crystal structure of the l state of bacteriorhodopsin at 1.20 angstrom resolution (10.1038/S41594-022-00762-2 )
• 6D26: crystal structure of the prostaglandin d2 receptor crth2 with fevipiprant (10.1016/J.MOLCEL.2018.08.009 )
• 6D27: crystal structure of the prostaglandin d2 receptor crth2 with cay10471 (10.1016/J.MOLCEL.2018.08.009 )
• 5LWY: revised crystal structure of the human adiponectin receptor 2 in complex with a c18 free fatty acid (10.1038/NATURE21714 )
• 5OLV: structure of the a2a-star2-bril562-luaa47070 complex at 2.0a obtained from in meso soaking experiments. (10.1038/S41598-017-18570-W )
• 5OLZ: structure of the a2a-star2-bril562-compound 4e complex at 1.9a obtained from bespoke co-crystallisation experiments. (10.1038/S41598-017-18570-W )
• 5OLG: structure of the a2a-star2-bril562-zm241385 complex at 1.86a obtained from in meso soaking experiments. (10.1038/S41598-017-18570-W )
• 5OLH: structure of the a2a-star2-bril562-vipadenant complex at 2.6a obtained from in meso soaking experiments. (10.1038/S41598-017-18570-W )
• 5OLO: structure of the a2a-star2-bril562-tozadenant complex at 3.1a obtained from in meso soaking experiments. (10.1038/S41598-017-18570-W )
• 4EA3: structure of the n/ofq opioid receptor in complex with a peptide mimetic (10.1038/NATURE11085 )
• 6KS1: crystal structure of the human adiponectin receptor 2 (10.1038/S42003-020-01160-4 )
• 5DHH: the crystal structure of nociceptin/orphanin fq peptide receptor (nop) in complex with sb-612111 (psi community target) (10.1016/J.STR.2015.07.024 )
• 5DHG: the crystal structure of nociceptin/orphanin fq peptide receptor (nop) in complex with c-35 (psi community target) (10.1016/J.STR.2015.07.024 )
• 7Z09: crystal structure of the ground state of bacteriorhodopsin at 1.05 angstrom resolution (10.1038/S41594-022-00762-2 )
• 7SR8: molecular mechanism of the the wake-promoting agent tak-925 (10.1038/S41467-022-30601-3 )
• 4X5M: crystal structure of semisweet in the inward-open conformation (10.1038/NCOMMS7112 )
• 6VUM: structure of nevanimibe-bound human tetrameric acat1 (10.1038/S41586-020-2295-8 )
• 4Z9G: crystal structure of human corticotropin-releasing factor receptor 1 (crf1r) in complex with the antagonist cp-376395 in a hexagonal setting with translational non-crystallographic symmetry (10.2174/1874467210666170110114727 )
• 5NM4: a2a adenosine receptor room-temperature structure determined by serial femtosecond crystallography (10.1038/S41467-017-00630-4 )
• 5NM2: a2a adenosine receptor cryo structure (10.1038/S41467-017-00630-4 )
• 1HMS: 1.4 angstroms structural studies on human muscle fatty acid binding protein: binding interactions with three saturated and unsaturated c18 fatty acids (10.1016/S0969-2126(00)00052-6 )
• 6WQA: 2.0a angstrom a2a adenosine receptor structure using xfel data collected in helium atmosphere. (10.1107/S2052252520012701 )
• 5CGD: structure of the human class c gpcr metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4- yl]benzonitrile - (htl14242) (10.1021/ACS.JMEDCHEM.5B00892 )
• 5CGC: structure of the human class c gpcr metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-4-fluoro-5-[6-(1h-pyrazol-1-yl)pyrimidin-4- yl]benzonitrile (10.1021/ACS.JMEDCHEM.5B00892 )
• 6LX8: x-ray structure of human pparalpha ligand binding domain-oleic acid co-crystals obtained by delipidation and cross-seeding (10.1016/J.ISCI.2020.101727 )
• 6W25: crystal structure of the melanocortin-4 receptor (mc4r) in complex with shu9119 (10.1126/SCIENCE.AAZ8995 )
• 5ZTY: crystal structure of human g protein coupled receptor (10.1016/J.CELL.2018.12.011 )
• 5ZTL: non-cryogenic structure of light-driven chloride pump having an ntq motif (10.1074/JBC.RA118.004038 )
• 5ZTK: synchrotron structure of light-driven chloride pump having an ntq motif (10.1074/JBC.RA118.004038 )
• 5UIW: crystal structure of cc chemokine receptor 5 (ccr5) in complex with high potency hiv entry inhibitor 5p7-ccl5 (10.1016/J.IMMUNI.2017.05.002 )
• 5EE7: crystal structure of the human glucagon receptor (gcgr) in complex with the antagonist mk-0893 (10.1038/NATURE17414 )
• 3PGU: phe3glu mutant of ecfadl (10.1073/PNAS.1018532108 )
• 6XYT: crystal structure of the o-state of the light-driven sodium pump kr2 in the pentameric form, ph 8.0 (10.1038/S41467-020-16032-Y )
• 2EV1: structure of rv1264n, the regulatory domain of the mycobacterial adenylyl cylcase rv1264, at ph 6.0 (10.1016/J.JMB.2007.04.013 )
• 2EV3: structure of rv1264n, the regulatory domain of the mycobacterial adenylyl cylcase rv1264, at ph 5.3 (10.1016/J.JMB.2007.04.013 )
• 2EV2: structure of rv1264n, the regulatory domain of the mycobacterial adenylyl cylcase rv1264, at ph 8.5 (10.1016/J.JMB.2007.04.013 )
• 2EV4: structure of rv1264n, the regulatory domain of the mycobacterial adenylyl cylcase rv1264, with a salt precipitant (10.1016/J.JMB.2007.04.013 )
• 4DQ3: bovine beta-lactoglobulin complex with oleic acid (10.1016/J.IJBIOMAC.2013.03.021 )
• 6XBW: cryo-em structure of v-atpase from bovine brain, state 1 (10.1038/S41467-020-17762-9 )
• 5TGZ: crystal structure of the human cannabinoid receptor cb1 (10.1016/J.CELL.2016.10.004 )
• 6WGT: crystal structure of htr2a with hallucinogenic agonist (10.1016/J.CELL.2020.08.024 )
• 6ZG4: structure of m1-star-t4l in complex with htl0009936 at 2.35a (10.1016/J.CELL.2021.11.001 )
• 7QAA: crystal structure of raralpha/rxralpha ligand binding domain heterodimer in complex with bms614 and oleic acid (10.1530/JME-22-0021 )
• 5DSG: structure of the m4 muscarinic acetylcholine receptor (m4-mt4l) bound to tiotropium (10.1038/NATURE17188 )
• 1FE3: crystal structure of human brain fatty acid binding protein oleic acid
• 6TPG: crystal structure of the orexin-2 receptor in complex with empa at 2.74 a resolution (10.1021/ACS.JMEDCHEM.9B01787 )
• 6TPJ: crystal structure of the orexin-2 receptor in complex with suvorexant at 2.76 a resolution (10.1021/ACS.JMEDCHEM.9B01787 )
• 6TPN: crystal structure of the orexin-2 receptor in complex with htl6641 at 2.61 a resolution (10.1021/ACS.JMEDCHEM.9B01787 )
• 3WEB: crystal structure of a niemann-pick type c2 protein from japanese carpenter ant in complex with oleic acid (10.1073/PNAS.1323928111 )
• 4LUR: crystal structure of zebrafish interphotoreceptor retinoid-binding protein (irbp) module 1
• 6BD4: crystal structure of human apo-frizzled4 receptor (10.1038/S41586-018-0447-X )
• 5VRA: 2.35-angstrom in situ mylar structure of human a2a adenosine receptor at 100 k (10.1038/NPROT.2017.135 )
• 7N6R: structure of nevanimibe bound human acat2
• 4N6H: 1.8 a structure of the human delta opioid 7tm receptor (psi community target) 05-mar-14 4n6h 1 jrnl title (10.1038/NATURE12944 )
• 2WQ9: crystal structure of rbp4 bound to oleic acid
• 2WQA: complex of ttr and rbp4 and oleic acid
• 3VKK: crystal structure of the covalent intermediate of human cytosolic beta-glucosidase-mannose complex
• 5G2C: the crystal structure of light-driven chloride pump clr (t102d) mutant at ph 4.5. (10.1038/NCOMMS12677 )
• 6KQI: structure of an allosteric modulator bound to the cb1 cannabinoid receptor 28-oct-20 6kqi 1 title (10.1038/S41589-019-0387-2 )
• 1LID: the adipocyte lipid-binding protein at 1.6 angstroms resolution: crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids
• 5JTB: crystal structure of the chimeric protein of a2aar-bril with bound iodide ions (10.1126/SCIADV.1602952 )
• 6GT3: crystal structure of the a2a-star2-bril562 in complex with azd4635 at 2.0a resolution
• 7O8N: nmhr light state structure at 7.5 ms (5 - 10 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 6BQH: crystal structure of 5-ht2c in complex with ritanserin (10.1016/J.CELL.2018.01.001 )
• 6WH4: crystal structure of htr2a with inverse agonist (10.1016/J.CELL.2020.08.024 )
• 1ICN: escherichia coli-derived rat intestinal fatty acid binding protein with bound myristate at 1.5 a resolution and i-fabparg106-->gln with bound oleate at 1.74 a resolution
• 5LXA: crystal structure of human adiponectin receptor 2 in complex with a c18 free fatty acid at 3.0 angstrom resolution (10.1038/NATURE21714 )
• 5VEW: structure of the human glp-1 receptor complex with pf-06372222 (10.1038/NATURE22378 )
• 6ZFZ: structure of m1-star-t4l in complex with 77-lh-28-1 at 2.17a (10.1016/J.CELL.2021.11.001 )
• 4RWD: xfel structure of the human delta opioid receptor in complex with a bifunctional peptide (10.1038/NSMB.2965 )
• 4S0V: crystal structure of the human ox2 orexin receptor bound to the insomnia drug suvorexant (10.1038/NATURE14035 )
• 5CE4: high resolution x-ray and neutron diffraction structure of h-fabp (10.1107/S2052252515024161 )
• 1G74: toward changing specificity: adipocyte lipid binding protein mutant, oleic acid bound form (10.1194/JLR.M300113-JLR200 )
• 4EIY: crystal structure of the chimeric protein of a2aar-bril in complex with zm241385 at 1.8a resolution (10.1126/SCIENCE.1219218 )
• 3X3B: crystal structure of the light-driven sodium pump kr2 in acidic state 27-may-15 3x3b 1 title (10.1038/NATURE14322 )
• 3X3C: crystal structure of the light-driven sodium pump kr2 in neutral state 27-may-15 3x3c 1 title (10.1038/NATURE14322 )
• 7Z0A: crystal structure of the ground state of bacteriorhodopsin at 1.22 angstrom resolution (10.1038/S41594-022-00762-2 )
• 6MXT: crystal structure of human beta2 adrenergic receptor bound to salmeterol and nb71 (10.1038/S41589-018-0145-X )
• 6FFH: crystal structure of mglur5 in complex with fenobam at 2.65 a (10.1021/ACS.JMEDCHEM.7B01722 )
• 6FFI: crystal structure of mglur5 in complex with mmpep at 2.2 a (10.1021/ACS.JMEDCHEM.7B01722 )
• 8CU6: crystal structure of a2aar-star2-s277-bril in complex with a novel a2a antagonist, lj-4517 (10.1021/ACS.JMEDCHEM.2C00462 )
• 8CU7: crystal structure of a2aar-star2-bril in complex with a novel a2a antagonist, lj-4517 (10.1021/ACS.JMEDCHEM.2C00462 )
• 6KRZ: crystal structure of the human adiponectin receptor 1 d208a mutant (10.1038/S42003-020-01160-4 )
• 6M9T: crystal structure of ep3 receptor bound to misoprostol-fa (10.1038/S41589-018-0160-Y )
• 4KPP: crystal structure of h+/ca2+ exchanger cax 10-jul-13 4kpp 1 title (10.1126/SCIENCE.1239002 )
• 7T71: crystal structure of mevalonate 3,5-bisphosphate decarboxylase from picrophilus torridus
• 5EPQ: structure at 1.75 a resolution of a glycosylated, lipid-binding, lipocalin-like protein (10.1107/S2052252516008903 )
• 2LKK: human l-fabp in complex with oleate (10.1016/J.BPJ.2012.04.039 )
• 7Q38: crystal structure of the mutant bacteriorhodopsin pressurized with argon (10.1038/S42003-022-03233-Y )
• 7Q35: crystal structure of the mutant bacteriorhodopsin pressurized with krypton (10.1038/S42003-022-03233-Y )
• 5MZJ: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with theophylline at 2.0a resolution (10.1016/J.STR.2017.06.012 )
• 7OTS: crystal structure of human monoacylglycerol lipase abhd6 in complex with oleic acid and octyl glucoside
• 7PX4: crystal structure of the adenosine a2a receptor (a2a-psb1-bril) in complex with preladenant conjugate psb-2113 (10.1002/ANIE.202115545 )
• 4X9X: biochemical roles for conserved residues in the bacterial fatty acid binding protein family (10.1074/JBC.M115.706820 )
• 6MD4: crystal structure of human ppargamma ligand binding domain in complex with rosiglitazone and oleic acid (10.7554/ELIFE.43320 )
• 6MD1: crystal structure of human ppargamma ligand binding domain in complex with gw9662 and oleic acid (10.7554/ELIFE.43320 )
• 6MD0: crystal structure of human ppargamma ligand binding domain in complex with oleic acid (10.7554/ELIFE.43320 )
• 4NC3: crystal structure of the 5-ht2b receptor solved using serial femtosecond crystallography in lipidic cubic phase. (10.1126/SCIENCE.1244142 )
• 7K15: crystal structure of the human leukotriene b4 receptor 1 in complex with selective antagonist mk-d-046 (10.1038/S41467-021-23149-1 )
• 7ARO: crystal structure of the non-ribose partial agonist luf5833 bound to the adenosine a2a receptor (10.1021/ACS.JMEDCHEM.0C01856 )
• 6O1T: bovine salivary protein form 30b with oleic acid (10.1371/JOURNAL.PONE.0206709 )
• 1J78: crystallographic analysis of the human vitamin d binding protein (10.1038/NSB754 )
• 1J7E: a structural basis for the unique binding features of the human vitamin d-binding protein (10.1038/NSB754 )
• 6ZDR: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with chromone 4d (10.1002/ANIE.202003788 )
• 6ZDV: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with chromone 5d (10.1002/ANIE.202003788 )
• 5G2D: the crystal structure of light-driven chloride pump clr (t102n) mutant at ph 4.5. (10.1038/NCOMMS12677 )
• 2JU8: solution-state structures of oleate-liganded lfabp, major form of 1:2 protein-ligand complex (10.1021/BI701092R )
• 2E9L: crystal structure of human cytosolic neutral beta-glycosylceramidase (klotho-related prote:klrp) complex with glucose and fatty acids (10.1074/JBC.M700832200 )
• 2E9M: crystal structure of human cytosolic neutral beta-glycosylceramidase (klotho-related prote:klrp) complex with galactose and fatty acids (10.1074/JBC.M700832200 )
• 5LX9: crystal structure of human adiponectin receptor 2 in complex with a c18 free fatty acid at 2.4 angstrom resolution (10.1038/NATURE21714 )
• 7JNI: crystal structure of the angiotensin ii type 2 receptoror (at2r) in complex with ema401
• 6JZH: structure of human a2a adenosine receptor in complex with zm241385 obtained from sfx experiments under atmospheric pressure (10.1107/S1600576719012846 )
• 6V9S: structure-based development of subtype-selective orexin 1 receptor antagonists (10.1073/PNAS.2002704117 )
• 7V3K: crystal structure of maj1
• 6ZG9: structure of m1-star-t4l in complex with gsk1034702 at 2.5a (10.1016/J.CELL.2021.11.001 )
• 7PYR: crystal structure of the adenosine a2a receptor (a2a-psb1-bril) in complex with preladenant conjugate psb-2115 (10.1002/ANIE.202115545 )
• 6ME3: xfel crystal structure of human melatonin receptor mt1 in complex with 2-phenylmelatonin (10.1038/S41586-019-1141-3 )
• 5WS3: crystal structures of human orexin 2 receptor bound to the selective antagonist empa determined by serial femtosecond crystallography at sacla (10.1016/J.STR.2017.11.005 )
• 7N6Q: structure of pppa bound human acat2
• 6I9F: solution structure of as-p18 reveals that nematode fatty acid binding proteins exhibit unusual structural features (10.1042/BSR20191292 )
• 6RZ8: crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ono-2080365 (10.1038/S41467-019-13348-2 )
• 6RZ9: crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ono-2770372 (10.1038/S41467-019-13348-2 )
• 6RZ6: crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ono-2570366 (c2221 space group) (10.1038/S41467-019-13348-2 )
• 6RZ7: crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ono-2570366 (f222 space group) (10.1038/S41467-019-13348-2 )
• 6RZ4: crystal structure of cysteinyl leukotriene receptor 1 in complex with pranlukast (10.1126/SCIADV.AAX2518 )
• 6RZ5: xfel crystal structure of the human cysteinyl leukotriene receptor 1 in complex with zafirlukast (10.1126/SCIADV.AAX2518 )
• 7YXA: xfel crystal structure of the human sphingosine 1 phosphate receptor 5 in complex with ono-5430608
• 3O19: structure-function analysis of human l-prostaglandin d synthase bound with fatty acid
• 2MO5: hifabp-oleate complex
• 5FJG: the crystal structure of light-driven chloride pump clr in ph 4.5.
• 5LWE: crystal structure of the human cc chemokine receptor type 9 (ccr9) in complex with vercirnon (10.1038/NATURE20606 )
• 5UVI: serial millisecond crystallography of membrane and soluble protein micro-crystals using synchrotron radiation (10.1107/S205225251700570X )
• 6JY7: structure of light-state marine bacterial chloride importer, nm-r3, with pulse laser (nd-1%) at 95k. (10.1126/SCIADV.AAY2042 )
• 6JY6: structure of dark-state marine bacterial chloride importer, nm-r3, with pulse laser (nd-1%) at 95k. (10.1126/SCIADV.AAY2042 )
• 6JY9: structure of light-state marine bacterial chloride importer, nm-r3, with cw laser (nd-3%) at 95k. (10.1126/SCIADV.AAY2042 )
• 6JY8: structure of dark-state marine bacterial chloride importer, nm-r3, with cw laser (nd-3%) at 95k. (10.1126/SCIADV.AAY2042 )
• 6JYE: structure of dark-state marine bacterial chloride importer, nm-r3, with pulse laser (nd-1%) at 140k. (10.1126/SCIADV.AAY2042 )
• 6JYD: structure of light-state marine bacterial chloride importer, nm-r3, with cw laser (nd-30%) at 95k. (10.1126/SCIADV.AAY2042 )
• 6JYC: structure of dark-state marine bacterial chloride importer, nm-r3, with cw laser (nd-30%) at 95k. (10.1126/SCIADV.AAY2042 )
• 6JYB: structure of light-state marine bacterial chloride importer, nm-r3, with cw laser (nd-10%) at 95k. (10.1126/SCIADV.AAY2042 )
• 6JYA: structure of dark-state marine bacterial chloride importer, nm-r3, with cw laser (nd-10%) at 95k. (10.1126/SCIADV.AAY2042 )
• 3UG9: crystal structure of the closed state of channelrhodopsin 27-jun-12 3ug9 1 title (10.1038/NATURE10870 )
• 5IUA: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with compound 12b at 2.2a resolution (10.1021/ACS.JMEDCHEM.6B00653 )
• 5IUB: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with compound 12x at 2.1a resolution (10.1021/ACS.JMEDCHEM.6B00653 )
• 5IU4: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with zm241385 at 1.7a resolution (10.1021/ACS.JMEDCHEM.6B00653 )
• 5IU7: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with compound 12c at 1.9a resolution (10.1021/ACS.JMEDCHEM.6B00653 )
• 5IU8: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with compound 12f at 2.0a resolution (10.1021/ACS.JMEDCHEM.6B00653 )
• 1LFO: liver fatty acid binding protein-oleate complex (10.1074/JBC.272.11.7140 )
• 6AB9: the crystal structure of the relaxed state of nonlabens marinus rhodopsin 3
• 6ME5: xfel crystal structure of human melatonin receptor mt1 in complex with agomelatine (10.1038/S41586-019-1141-3 )
• 6ME2: xfel crystal structure of human melatonin receptor mt1 in complex with ramelteon (10.1038/S41586-019-1141-3 )
• 6S0Q: structure of the a2a adenosine receptor determined at swissfel using native-sad at 4.57 kev from 50,000 diffraction patterns (10.1107/S2052252520011379 )
• 1GT6: s146a mutant of thermomyces (humicola) lanuginosa lipase complex with oleic acid (10.1046/J.1432-1327.2002.02786.X )
• 2AF9: crystal structure analysis of gm2-activator protein complexed with phosphatidylcholine (10.1021/BI050668W )
• 6YX9: cryogenic human adiponectin receptor 2 (adipor2) at 2.4 a resolution determined by serial crystallography (ssx) using crystaldirect (10.1016/J.CRMETH.2021.100102 )
• 6YXG: cryogenic human adiponectin receptor 2 (adipor2) with tb-xo4 ligand determined by serial crystallography (ssx) using crystaldirect (10.1016/J.CRMETH.2021.100102 )
• 6YXF: cryogenic human adiponectin receptor 2 (adipor2) with gd-do3 ligand determined by serial crystallography (ssx) using crystaldirect (10.1016/J.CRMETH.2021.100102 )
• 6YXD: room temperature structure of human adiponectin receptor 2 (adipor2) at 2.9 a resolution determined by serial crystallography (ssx) using crystaldirect (10.1016/J.CRMETH.2021.100102 )
• 7AKX: crystal structure of the viral rhodopsin olpvr1 in p1 space group (10.1038/S41467-020-19457-7 )
• 5G54: the crystal structure of light-driven chloride pump clr at ph 4.5 (10.1038/NCOMMS12677 )
• 6OL9: structure of the m5 muscarinic acetylcholine receptor (m5-t4l) bound to tiotropium (10.1073/PNAS.1914446116 )
• 5K2D: 1.9a angstrom a2a adenosine receptor structure with mr phasing using xfel data (10.1126/SCIADV.1600292 )
• 5K2B: 2.5 angstrom a2a adenosine receptor structure with mr phasing using xfel data (10.1126/SCIADV.1600292 )
• 5K2C: 1.9 angstrom a2a adenosine receptor structure with sulfur sad phasing and phase extension using xfel data (10.1126/SCIADV.1600292 )
• 5K2A: 2.5 angstrom a2a adenosine receptor structure with sulfur sad phasing using xfel data (10.1126/SCIADV.1600292 )
• 5XRA: crystal structure of the human cb1 in complex with agonist am11542 (10.1038/NATURE23272 )
• 6FJ3: high resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist. (10.1038/S41594-018-0151-4 )
• 1GNI: human serum albumin complexed with cis-9-octadecenoic acid (oleic acid) (10.1006/JMBI.2000.5208 )
• 4K5Y: crystal structure of human corticotropin-releasing factor receptor 1 (crf1r) in complex with the antagonist cp-376395 (10.1038/NATURE12357 )
• 4YZI: crystal structure of blue-shifted channelrhodopsin mutant (t198g/g202a) (10.1038/NCOMMS8177 )
• 7KAY: crystal structure of ohya(e82a)-18:1 complex from staphylococcus aureus (10.1074/JBC.RA120.016818 )
• 7KAZ: crystal structure of ohya(e82a)-18:1/h18:0-fad complex from staphylococcus aureus (10.1074/JBC.RA120.016818 )
• 6HLP: crystal structure of the neurokinin 1 receptor in complex with the small molecule antagonist netupitant (10.1038/S41467-018-07939-8 )
• 6HLO: crystal structure of the neurokinin 1 receptor in complex with the small molecule antagonist aprepitant (10.1038/S41467-018-07939-8 )
• 4OR2: human class c g protein-coupled metabotropic glutamate receptor 1 in complex with a negative allosteric modulator (10.1126/SCIENCE.1249489 )
• 7O8V: nmhr light state structure at 55 ms (50 - 60 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8T: nmhr light state structure at 37.5 ms (35 - 40 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8U: nmhr light state structure at 45 ms (40 - 50 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8R: nmhr light state structure at 27.5 ms (25 - 30 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8S: nmhr light state structure at 32.5 ms (30 - 35 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8P: nmhr light state structure at 17.5 ms (15 - 20 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8Q: nmhr light state structure at 22.5 ms (20 - 25 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8Z: anomalous bromide substructure of nmhr under continuous illumination determined at 13.7 kev with serial crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8Y: anomalous bromide substructure of nmhr under dark state conditions determined at 13.7 kev with serial crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8F: nmhr dark state structure determined by serial femtosecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8G: nmhr light state structure at 10 ps after photoexcitation determined by serial femtosecond crystallography (with extrapolated, dark and light dataset) (10.1126/SCIENCE.ABJ6663 )
• 7O8O: nmhr light state structure at 12.5 ms (10 - 15 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8L: nmhr dark state structure determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8M: nmhr light state structure at 2.5 ms (0 - 5 ms) after photoexcitation determined by serial millisecond crystallography (10.1126/SCIENCE.ABJ6663 )
• 7O8J: nmhr light state structure at 20 us after photoexcitation determined by serial femtosecond crystallography (with extrapolated, dark and light dataset) (10.1126/SCIENCE.ABJ6663 )
• 7O8K: nmhr light state structure at 300 us after photoexcitation determined by serial femtosecond crystallography (with extrapolated, dark and light dataset) (10.1126/SCIENCE.ABJ6663 )
• 7O8H: nmhr light state structure at 10 ns after photoexcitation determined by serial femtosecond crystallography (with extrapolated, dark and light dataset) (10.1126/SCIENCE.ABJ6663 )
• 7O8I: nmhr light state structure at 1 us after photoexcitation determined by serial femtosecond crystallography (with extrapolated, dark and light dataset) (10.1126/SCIENCE.ABJ6663 )
• 6PS3: xfel beta2 ar structure by ligand exchange from timolol to carvedilol. (10.1107/S2052252519013137 )
• 6PS2: xfel beta2 ar structure by ligand exchange from timolol to alprenolol. (10.1107/S2052252519013137 )
• 6PS1: xfel beta2 ar structure by ligand exchange from alprenolol to timolol. (10.1107/S2052252519013137 )
• 6PS0: xfel beta2 ar structure by ligand exchange from alprenolol to carazolol. (10.1107/S2052252519013137 )
• 6PS7: xfel a2ar structure by ligand exchange from luf5843 to zm241385. (10.1107/S2052252519013137 )
• 6PS6: xfel beta2 ar structure by ligand exchange from timolol to timolol. (10.1107/S2052252519013137 )
• 6PS5: xfel beta2 ar structure by ligand exchange from timolol to propranolol. (10.1107/S2052252519013137 )
• 6PS4: xfel beta2 ar structure by ligand exchange from timolol to ici-118551. (10.1107/S2052252519013137 )
• 4IKX: crystal structure of peptide transporter pot (e310q mutant) (10.1073/PNAS.1301079110 )
• 4IKY: crystal structure of peptide transporter pot (e310q mutant) in complex with sulfate (10.1073/PNAS.1301079110 )
• 4IKV: crystal structure of peptide transporter pot (10.1073/PNAS.1301079110 )
• 4IKW: crystal structure of peptide transporter pot in complex with sulfate (10.1073/PNAS.1301079110 )
• 2AG4: crystal structure analysis of gm2-activator protein complexed with phosphatidylcholine (10.1021/BI050668W )
• 1FK5: structural basis of non-specific lipid binding in maize lipid-transfer protein complexes with oleic acid revealed by high-resolution x-ray crystallography (10.1006/JMBI.2001.4559 )
• 2FLJ: fatty acid binding protein from locust flight muscle in complex with oleate (10.1021/BI060224F )
• 6DJ6: the x-ray crystal structure of the streptococcus pneumoniae fatty acid kinase (fak) b2 protein loaded with cis-oleic acid to 1.9 angstrom resolution
• 5UEN: crystal structure of the human adenosine a1 receptor a1ar-bril in complex with the covalent antagonist du172 at 3.2a resolution (10.1016/J.CELL.2017.01.042 )
• 5WQC: crystal structure of human orexin 2 receptor bound to the selective antagonist empa determined by the synchrotron light source at spring- 8. (10.1016/J.STR.2017.11.005 )
• 7KHR: cryo-em structure of bafilomycin a1-bound intact v-atpase from bovine brain
• 4U4T: structure of a nitrate/nitrite antiporter nark in nitrate-bound inward-open state (10.1038/NCOMMS8097 )
• 4U4W: structure of a nitrate/nitrite antiporter nark in nitrate-bound occluded state (10.1038/NCOMMS8097 )
• 4U4V: structure of a nitrate/nitrite antiporter nark in apo inward-open state (10.1038/NCOMMS8097 )
• 6B73: crystal structure of a nanobody-stabilized active state of the kappa- opioid receptor (10.1016/J.CELL.2017.12.011 )
• 5UNG: xfel structure of human angiotensin ii type 2 receptor (orthorhombic form) in complex with compound 1 (n-benzyl-n-(2-ethyl-4-oxo-3-{[2'- (2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl] methyl}-3,4- dihydroquinazolin-6-yl)thiophene-2-carboxamide) (10.1038/NATURE22035 )
• 7SQO: structure of the orexin-2 receptor(ox2r) bound to tak-925, gi and scfv16
• 1SX6: crystal structure of human glycolipid transfer protein in lactosylceramide-bound form (10.1038/NATURE02856 )
• 3LSP: crystal structure of dest bound to descb promoter and oleoyl-coa (10.1038/NSMB.1847 )
• 6PRZ: xfel beta2 ar structure by ligand exchange from alprenolol to alprenolol. (10.1107/S2052252519013137 )
• 6AQF: crystal structure of a2aar-bril in complex with the antagonist zm241385 produced from pichia pastoris (10.1016/J.CELL.2017.12.004 )
• 6YC2: crystal structure of the light-driven sodium pump kr2 in the pentameric form at room temperature, ph 8.0 (10.1038/S41467-020-16032-Y )
• 6YC0: crystal structure of the steady-state-smx activated state of the light-driven sodium pump kr2 in the pentameric form at room temperature, ph 8.0 (10.1038/S41467-020-16032-Y )
• 6YC4: crystal structure of the steady-state activated state of the light- driven sodium pump kr2 in the pentameric form at room temperature, ph 8.0 (10.1038/S41467-020-16032-Y )
• 8DU3: crystal structure of a2aar-star2-bril in complex with compound 21a (10.1016/J.EJMECH.2022.114620 )
• 5N2R: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with psb36 at 2.8a resolution (10.1016/J.STR.2017.06.012 )
• 7Z0C: crystal structure of the k state of bacteriorhodopsin at 1.53 angstrom resolution (10.1038/S41594-022-00762-2 )
• 3ODU: the 2.5 a structure of the cxcr4 chemokine receptor in complex with small molecule antagonist it1t (10.1126/SCIENCE.1194396 )
• 3O22: structure-function analysis of human l-prostaglandin d synthase bound with fatty acid
• 3O2Y: structure-function analysis of human l-prostaglandin d synthase bound with fatty acid
• 4OO9: structure of the human class c gpcr metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator mavoglurant (10.1038/NATURE13396 )
• 6CSM: crystal structure of the natural light-gated anion channel gtacr1 (10.1038/S41586-018-0504-5 )
• 6CSN: crystal structure of the designed light-gated anion channel ic++ at ph8.5 (10.1038/S41586-018-0504-5 )
• 6CSO: crystal structure of the designed light-gated anion channel ic++ at ph6.5 (10.1038/S41586-018-0504-5 )
• 5O9H: crystal structure of thermostabilised human c5a anaphylatoxin chemotactic receptor 1 (c5ar) in complex with ndt9513727 (10.1038/NATURE25025 )
• 1PMP: crystallographic studies on a family of cellular lipophilic transport proteins. refinement of p2 myelin protein and the structure determination and refinement of cellular retinol-binding protein in complex with all-trans-retinol (10.1006/JMBI.1993.1238 )
• 5MZP: crystal structure of stabilized a2a adenosine receptor a2ar-star2-bril in complex with caffeine at 2.1a resolution (10.1016/J.STR.2017.06.012 )
• 2AG2: crystal structure analysis of gm2-activator protein complexed with phosphatidylcholine (10.1021/BI050668W )
• 6KUX: crystal structures of the alpha2a adrenergic receptor in complex with an antagonist rsc.
• 6KUW: crystal structure of human alpha2c adrenergic g protein-coupled receptor.
• 6S0L: structure of the a2a adenosine receptor determined at swissfel using native-sad at 4.57 kev from all available diffraction patterns (10.1107/S2052252520011379 )
• 5GLI: human endothelin receptor type-b in the ligand-free form (10.1038/NATURE19319 )
• 6CM4: structure of the d2 dopamine receptor bound to the atypical antipsychotic drug risperidone (10.1038/NATURE25758 )
• 6GPX: crystal structure of ccr2a in complex with mk-0812 (10.1016/J.STR.2018.10.027 )
• 2ZOX: crystal structure of the covalent intermediate of human cytosolic beta-glucosidase (10.1016/J.BBRC.2008.07.089 )
• 6K6K: the crystal structure of light-driven cyanobacterial chloride importer (n63a/p118a) mastigocladopsis repens
• 6K6J: the crystal structure of light-driven cyanobacterial chloride importer from mastigocladopsis repens with bromide ion
• 6K6I: the crystal structure of light-driven cyanobacterial chloride importer from mastigocladopsis repens
• 6LUQ: haloperidol bound d2 dopamine receptor structure inspired discovery of subtype selective ligands (10.1038/S41467-020-14884-Y )
• 6ZZX: structure of low-light grown chlorella ohadii photosystem i (10.1038/S41477-021-00983-1 )
• 6ZZY: structure of high-light grown chlorella ohadii photosystem i (10.1038/S41477-021-00983-1 )
• 4IB4: crystal structure of the chimeric protein of 5-ht2b-bril in complex with ergotamine (10.1126/SCIENCE.1232808 )
• 6DRY: structural determinants of activation and biased agonism at the 5-ht2b receptor (10.1038/S41594-018-0116-7 )
• 6DRZ: structural determinants of activation and biased agonism at the 5-ht2b receptor (10.1038/S41594-018-0116-7 )